Cafepharma Today

July 11 2025 - Karyopharm lays off more workers as hunt for strategic alternatives turns up short
Karyopharm lays off more workers as hunt for strategic alternatives turns up short
Biotech startups board
FDA rejections: we read 200 CRLs so you don't have to
Pharma/Biotech general discussion board
Case builds for Biogen, Stoke's Dravet syndrome drug
Biogen board
FDA approves Moderna COVID vaccine for kids under 12 at higher risk
Moderna board
*please scroll down for all the latest news*

Check open job listings in your area
Click here to get the top four headlines in your inbox Mon-Fri (free)

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Karyopharm lays off more workers as hunt for strategic alternatives turns up short
Fierce Biotech
Friday, July 11, 2025 - 11:53am
tags:
Karyopharm Therapeutics, layoffs
FDA rejections: we read 200 CRLs so you don't have to
BioSpace
Friday, July 11, 2025 - 11:51am
tags:
FDA, regulatory, CRLs, Eli Lilly, Kisunla, Sarepta Therapeutics, Vyondys 53, Gilead Sciences, Sunlenca, HUV, DMD, Alzheimer's disease
Walgreens shareholders approve $10 billion private equity buyout
Forbes
Friday, July 11, 2025 - 11:47am
tags:
Walgreens, Sycamore Partners, private equity, M&A
Abbott gains national CMS coverage for tricuspid valve repair
Medtech Dive
Friday, July 11, 2025 - 11:43am
tags:
Abbott Labs, Medtech, CMS, TriClip, tricuspid valve regurgitation
Non-opioid pain drug maker Pacira lays off 71 in California, retires facility in manufacturing upgrade
Fierce Pharma
Friday, July 11, 2025 - 11:41am
tags:
Pacira, layoffs, California, non-opioid pain treatments, EXPAREL
‘Weak evidence’ and an ‘unpleasant’ odor: FDA sheds light on drug refusal process
Fierce Pharma
Friday, July 11, 2025 - 11:39am
tags:
FDA, regulatory, CRLs, drug approvals
Capricor sinks after FDA rejects drug for muscle disease
MSN/Bloomberg
Friday, July 11, 2025 - 11:31am
tags:
Capricor, FDA, cell therapy, DMD, Duchenne Muscular Dystrophy
Case builds for Biogen, Stoke's Dravet syndrome drug
Pharmaphorum
Friday, July 11, 2025 - 11:28am
tags:
Biogen, Stoke Therapeutics, Dravet syndrome, zorevunersen
Bayer bags first world approval for hot flash therapy
Pharmaphorum
Friday, July 11, 2025 - 11:27am
tags:
Bayer, Astellas, hot flashes, menopause, Lynkuet, Veozah
Early measles drug R&D kicks into gear as U.S. records record outbreak
Pharma Voice
Friday, July 11, 2025 - 11:24am
tags:
measles, Invivyd, NanoViricides, R&D
FDA approves Moderna COVID vaccine for kids under 12 at higher risk
Cidrap
Thursday, July 10, 2025 - 10:54pm
tags:
Moderna Therapeutics, COVID-19, vaccines, mRNA-1273, FDA
With Varda Space, leading Silicon Valley players make big bet on making drugs in space
TechCrunch
Thursday, July 10, 2025 - 10:51pm
tags:
Varda Space, funding, drug manufacturing, Space
FDA approves Purespring’s application for Phase I/II trial of IgAN treatment
Clinical Trials Arena
Thursday, July 10, 2025 - 10:48pm
tags:
Purespring Therapeutics, PS-002, FDA, clinical trials, IgA nephropathy
Soleno sales of new Prader-Willi drug rise faster than expected
BioPharma Dive
Thursday, July 10, 2025 - 10:44pm
tags:
Soleno, Prader-Willi Syndrome, Vykat
Jazz Pharmaceuticals Names Renee Gala as President & CEO
Contract Pharma
Thursday, July 10, 2025 - 10:41pm
tags:
Jazz Pharma, Renee Gala
Delaware Court Sides With Zantac Makers on Cancer Claims
MSN/Bloomberg
Thursday, July 10, 2025 - 10:39pm
tags:
Zantac, legal, Delaware, GSK, Pfizer, Boehinger Ingelheim
AbbVie pays $700M upfront for trispecific rival to J&J, Pfizer in blood cancer
Fierce Biotech
Thursday, July 10, 2025 - 11:43am
tags:
AbbVie, Ichnos, JNJ, Tecvayli, Multiple Myeloma
Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win
Yahoo/Reuters
Thursday, July 10, 2025 - 11:40am
tags:
Pfizer, BioNTech, UK, COVID-19, Moderna Therapeutics, vaccines, patents
Ultragenyx, Mereo hammered for their surprise miss in brittle bone disease
Investors Business Daily
Thursday, July 10, 2025 - 11:38am
tags:
Ultragenyx, Mereo BioPharma, brittle bone disease, setrusumab
Renasant Bio, chasing drugs for ADPKD, raises $55M in seed funding
BioPharma Dive
Thursday, July 10, 2025 - 11:35am
tags:
Renasant Bio, ADPKD, funding, cystic fibrosis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Hexanitrogen Energies
In the Pipeline
Thinking About Covalent Drug Reactivity
In the Pipeline
Tell the Bot to Tell the Bot About the Bot
In the Pipeline
The Fourth Of July, 2025
In the Pipeline
New Assays Are Always Welcome
In the Pipeline
Down In the Reaction Details
In the Pipeline
The "Healthy Vaccinee" Effect
In the Pipeline
The Continuing Crisis, Part XVI: Get the Hell Out of Your Building
In the Pipeline
Tiny Crystals from Small Extracts
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.